Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
Aimmune Therapeutics, Inc. (AIMT)
Sector: Healthcare; Industry: Biotechnology

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-10-13 Societe des Produits Nestle S.A. 10%-Owner Buy 54,117,287 $34.50 $1,867,046,402 No
2020-04-22 Societe des Produits Nestle S.A. 10%-Owner Buy 1,525,634 $31.96 $200,002,049 No
2018-11-28 Nestle Health Science US Holdings, Inc. 10%-Owner Buy 4,175,029 $30.66 $128,000,003 No
2020-03-18 ENRIGHT PATRICK G Director Buy 125,000 $11.36 $1,420,045 No
2020-03-13 Oxtoby Andrew Chief Commercial Officer Buy 3,000 $14.76 $44,266 No
2020-03-12 BJERKHOLT ERIC Chief Financial Officer Buy 1,000 $15.10 $15,100 No
2020-03-10 Dallas Jayson Donald Alexander President and CEO Buy 2,665 $18.74 $49,934 No
2020-03-09 BJERKHOLT ERIC Chief Financial Officer Buy 1,000 $18.97 $18,970 No
2020-01-16 Sheehy Douglas T. See Remarks Sell 400 $37.00 $14,800 Yes
2020-01-02 ADELMAN DANIEL C MD Chief Medical Officer Sell 20,000 $35.00 $700,038 Yes
2019-12-26 Sheehy Douglas T. See Remarks Sell 10,000 $33.03 $330,322 Yes
2019-12-09 ADELMAN DANIEL C MD Chief Medical Officer Sell 20,000 $30.04 $600,716 Yes
2019-09-18 BJERKHOLT ERIC Chief Financial Officer Buy 1,550 $22.57 $34,977 No
2018-11-19 Barrowcliffe Susan E. General Manager, Europe Sell 40,000 $30.04 $1,201,600 Yes
2018-11-19 Dallas Jayson Donald Alexander President and CEO Buy 3,650 $27.56 $100,587 No
2018-06-13 BJERKHOLT ERIC Chief Financial Officer Buy 1,600 $30.41 $48,663 No
2018-06-11 DILLY STEPHEN GEORGE President and CEO Sell 29,457 $30.83 $908,301 Yes
2018-06-08 DILLY STEPHEN GEORGE President and CEO Sell 105,169 $30.92 $3,251,993 Yes
2018-06-05 DILLY STEPHEN GEORGE See Remarks Sell 165,374 $32.14 $5,315,183 Yes
2018-05-22 Sheehy Douglas T. See Remarks Sell 3,296 $33.00 $108,768 Yes
2018-03-05 Sheehy Douglas T. See Remarks Sell 3,523 $36.52 $128,667 Yes
2018-03-01 Rozenman Mary M. See Remarks Sell 1,807 $33.10 $59,812 Yes
2018-02-22 Tammenoms Bakker Juliet 10%-Owner Buy 9,375 $32.00 $300,000 No
2018-02-22 ENRIGHT PATRICK G 10%-Owner, Director Buy 15,593 $32.00 $498,976 No
2018-02-26 Iwicki Mark T Director Buy 9,375 $32.00 $300,000 No
2018-02-26 FALBERG KATHRYN E Director Buy 30,000 $32.00 $960,000 No
2018-02-26 BJERKHOLT ERIC Chief Financial Officer Buy 3,125 $32.00 $100,000 No
2018-02-05 Sheehy Douglas T. See Remarks Sell 1,648 $35.87 $59,114 Yes
2018-02-01 Rozenman Mary M. See Remarks Sell 6,592 $35.36 $233,088 Yes
2018-01-24 Sheehy Douglas T. See Remarks Sell 1,875 $38.15 $71,531 Yes

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

MGM Resorts International (MGM) - If we were to pick one of the easy trade from the crash, it has to be MGM, checkout the impressive insider buying after crash. Do you really need more confidence to pull the trigger? That's the mental edge you need to work against fear.